Showing results (591-600 of 684) with videos related to

Sort By:
Pageof 69
Journal of Molecular Biology|August 14, 2022
Ligand-mediated Structural Dynamics of a Mammalian Pancreatic KATP ChannelMin Woo Sung, Camden M Driggers, Barmak Mostofian, et al.
Therapeutic Advances in Medical Oncology|September 25, 2023
Role of immunotherapy in chondrosarcoma: A case report and review of the literatureAdam J Cohen-Nowak, Danielle B Dressler, Adam Rock, et al.
American Journal of Medical Genetics. Part A|April 17, 2026
Rate and Type of Surgery and Prevalence of Malignancy in Patients With Ollier's Disease and Maffucci SyndromeMichael J Colello, Annika Y Myers, Jordan O Gasho, et al.
Transplantation|June 27, 2000
Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patientsS Singhal, J C Shaw, J Ainsworth, et al.
BMC Public Health|May 26, 2012
Working on wellness (WOW): a worksite health promotion intervention programmeTracy L Kolbe-Alexander, Karin I Proper, Estelle V Lambert, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 15, 2017
Glycated haemoglobin (HbA1c ) and fasting plasma glucose relationships in sea-level and high-altitude settingsJ C Bazo-Alvarez, R Quispe, T D Pillay, et al.
Gut|December 22, 1999
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipientD Mutimer, D Pillay, P Shields, et al.
Leukemia Research|September 23, 2008
Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantationZ Y Lim, G Cook, P R Johnson, et al.
The Journal of Physiology|April 20, 2021
Connexin 46 and connexin 50 gap junction channel properties are shaped by structural and dynamic features of their N-terminal domainsBenny Yue, Bassam G Haddad, Umair Khan, et al.
Journal of Medical Virology|October 26, 2006
Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumabS E Moses, Z Y Lim, M Sudhanva, et al.
Pageof 69